Dermatology Institute of Boston

The Dermatology Institute of Boston is a specialized medical and cosmetic dermatology practice that also serves as a prominent clinical research site. Founded by Dr. Emmy Graber, the institute provides comprehensive dermatological care while maintaining a dedicated division for Phase 2 through Phase 4 clinical trials. The organization collaborates with major pharmaceutical and biotechnology companies to evaluate novel therapies for conditions such as acne, alopecia areata, and atopic dermatitis. By integrating clinical practice with research, the institute offers patients access to emerging treatments and contributes to the development of new dermatological standards. It is recognized as a key center for dermatological innovation in the New England region.